Jason Okazaki
Chief Executive Officer at ASSEMBLY BIOSCIENCES, INC.
Net worth: 183 886 $ as of 2024-03-30
Profile
Jason A.
Okazaki is currently the President, Chief Executive Officer & Director at Assembly Biosciences, Inc. He is also a Director at Kite Pharma UK Ltd.
Additionally, he is a Member of the New York State Bar Association and The State Bar of California.
Previously, he held positions as a Director at Kite Pharma, Inc. and as a Senior Vice President-Legal & Assistant Secretary at Gilead Sciences, Inc. Mr. Okazaki completed his undergraduate degree at Stanford University and his graduate degree at the University of California, Hastings.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-31 | 13,826 ( 0.25% ) | 183 886 $ | 2024-03-30 |
Jason Okazaki active positions
| Companies | Position | Start |
|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. | Chief Executive Officer | 2022-12-31 |
Kite Pharma UK Ltd.
 Kite Pharma UK Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Kite Pharma UK Ltd. is a subsidiary of Gilead Sciences, Inc. that engages in research and develops clinical trials. The private company is based in London, UK. | Director/Board Member | 2017-10-15 |
The State Bar of California
 The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Corporate Officer/Principal | - |
New York State Bar Association
 New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Corporate Officer/Principal | - |
Former positions of Jason Okazaki
| Companies | Position | End |
|---|---|---|
| GILEAD SCIENCES, INC. | General Counsel | - |
| KITE PHARMA INC | Director/Board Member | - |
Training of Jason Okazaki
| Stanford University | Undergraduate Degree |
| University of California, Hastings | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| ASSEMBLY BIOSCIENCES, INC. | Health Technology |
| Private companies | 4 |
|---|---|
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Commercial Services |
The State Bar of California
The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Commercial Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Kite Pharma UK Ltd.
Kite Pharma UK Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Kite Pharma UK Ltd. is a subsidiary of Gilead Sciences, Inc. that engages in research and develops clinical trials. The private company is based in London, UK. | Commercial Services |
- Stock Market
- Insiders
- Jason Okazaki
